Longevity
Cellular Senescence: The 'Zombie Cells' Behind Ageing
As we age, some cells stop dividing but refuse to die — lingering as so-called 'zombie cells' that leak inflammatory signals into the tissue around them. Here's what cellular senescence really is, why it's one of the hallmarks of ageing, and the honest state of the science on clearing these cells.
There's a vivid nickname in ageing research that captures one of its strangest ideas: zombie cells. The proper term is cellular senescence, and it describes cells that have stopped dividing — as worn-out cells should — but then refuse to do the other thing worn-out cells are supposed to do, which is quietly die off and get cleared away. Instead they linger, neither properly alive in the working sense nor dead, and as they pile up over the years they actively make the tissue around them worse.
Cellular senescence is one of the twelve hallmarks of ageing — the defined biological processes that, together, add up to getting older 2. It's also one of the most genuinely interesting, because unlike some hallmarks it has produced a clear, testable idea: if zombie cells drive ageing, what happens if we clear them out? This article explains what these cells actually are, why the body makes them in the first place, how they contribute to ageing, and the honest state of the science on doing something about them.
What a senescent cell actually is
Most of your cells can divide to replace themselves, and they do so throughout life. Cellular senescence is a kind of permanent retirement: in response to certain stresses, a cell switches into a state where it will never divide again, and it locks that decision in 1.
The triggers are exactly the kinds of damage you'd expect to accumulate with age. A cell can become senescent because its telomeres — the protective caps on its chromosomes — have worn too short after many divisions; because its DNA has been damaged beyond easy repair; or because it has been pushed by stress signals from its environment 1. In each case, senescence is a sensible local decision: a cell that might otherwise divide in a damaged, error-prone way is taken permanently off the field.
The problem is what the cell does after it retires. A senescent cell doesn't go quiet. It becomes metabolically active in a new and unhelpful way, and crucially it resists the normal signals that would tell a damaged cell to self-destruct. That combination — can't divide, won't die — is exactly why "zombie cell" stuck.
Not all bad: why the body makes them on purpose
It would be easy to read all this as a simple malfunction, but senescence is genuinely useful in the right context — which is exactly why evolution kept it 1.
Two roles stand out. First, wound healing: when tissue is injured, cells become senescent temporarily as part of the orderly repair process, then are cleared once the job is done. Second, and more importantly, senescence is one of the body's defences against cancer. A cell that has acquired dangerous genetic damage is a candidate to become a tumour; flipping it into permanent senescence is a way to stop it dividing into one. In other words, the same process that troubles us in old age is, earlier in life, a tumour-suppressing safety mechanism.
This is a recurring theme across the hallmarks of ageing: many of them are responses that are protective at the right dose and in the right moment, and only become harmful when they're chronic or excessive. Senescence is a textbook example. The issue isn't that senescent cells exist — it's that, with age, we both make more of them and clear them less efficiently, so they accumulate.
How zombie cells drive ageing
The single most important thing a senescent cell does is talk. It secretes a cocktail of inflammatory molecules, growth factors and enzymes that researchers call the senescence-associated secretory phenotype — mercifully shortened to the SASP 1. The SASP is how one retired, damaged cell turns into a problem for its whole neighbourhood.
Those secreted signals do three unhelpful things. They inflame the surrounding tissue, contributing directly to the chronic, low-grade inflammation that ageing research now treats as a hallmark in its own right — the process nicknamed inflammaging, which we cover in Chronic Inflammation and Ageing. They can nudge nearby healthy cells into becoming senescent themselves, so the burden spreads. And over time they degrade the structure and function of the tissue, which is part of why organs work less well with age 1.
This is also where senescence connects to the body's declining ability to repair itself. As inflammatory SASP signals accumulate and the tissue environment deteriorates, the reservoirs of stem cells that renew our tissues are worn down faster — another hallmark, stem-cell exhaustion. It's a good illustration of the central lesson of the hallmarks framework: they are not separate problems but an interconnected web, each one feeding the others.
Can we clear them? The senolytics story
Here is the genuinely exciting part — and also the part where it's most important to stay honest.
If accumulated senescent cells drive ageing, then removing them should help. That hypothesis was tested directly in mice, and the results were striking. In a landmark 2011 study, researchers engineered mice so that senescent cells could be selectively destroyed; clearing those cells delayed the onset of several age-related disorders 3. A follow-up in 2016 went further: removing naturally occurring senescent cells from normally ageing mice extended their healthy median lifespan and improved the function of several organs 4.
Those experiments used genetic tricks, not medicines. The practical breakthrough came when scientists identified actual drugs — christened senolytics — that preferentially kill senescent cells while largely sparing healthy ones. In 2018, a combination of the cancer drug dasatinib with the plant flavonoid quercetin was shown to improve physical function and even extend lifespan in old mice 5. For the first time, the "clear the zombie cells" idea had a pharmacological tool.
The crucial question is what happens in people, and here the evidence is still in its infancy. The first human studies are small, short, early-phase trials in specific diseases — not anti-ageing studies in healthy adults. A 2019 first-in-human pilot tested dasatinib plus quercetin in patients with idiopathic pulmonary fibrosis, a serious lung disease, and found preliminary signs of improved physical function 6. Another 2019 trial reported that the same combination measurably reduced the number of senescent cells in people with diabetic kidney disease 7. These are important proofs of concept — they show senolytics can do something measurable in humans — but they are a very long way from showing that clearing senescent cells safely slows ageing in otherwise healthy people.
A word on supplements and "natural senolytics"
Because quercetin and another flavonoid, fisetin, appear in senolytic research and are sold cheaply as supplements, a whole market has sprung up promising "senolytic" anti-ageing benefits in a capsule. This is where caution matters most. The doses, schedules and combinations used in research are specific and physician-supervised; they are not the same as taking a daily supplement, and buying fisetin off a shelf is not a validated way to clear senescent cells or slow ageing. The honest summary is that senolytics are a promising field of research, not a proven product you can purchase. Treat any supplement marketed on the back of these studies with healthy scepticism.
What you can genuinely do today
It would be a shame if all of this left you waiting for a future pill, because the levers that actually work right now are already in your hands — and they happen to act on senescence too.
The standout is physical activity. Exercise has been described in the research literature as acting like a "polypill" for ageing, favourably influencing a wide range of the hallmarks at once 8 — and part of that benefit appears to involve helping the body manage its burden of senescent cells and the inflammation they generate. Alongside it sit the same unglamorous foundations that support every hallmark: a mostly whole-food diet, protecting your sleep (when much cellular clean-up happens), managing chronic stress, and not smoking — smoking being a direct driver of the DNA damage that pushes cells into senescence in the first place.
None of this is as headline-grabbing as "clearing zombie cells", but it is what the evidence actually supports today, and it works on the same underlying biology.
How we think about it at Cureon
Senescence is one of the topics people ask us about after reading an exciting headline — and our answer is the same one we give for every fashionable longevity intervention. We don't offer senolytic drugs, and we'd gently steer you away from anyone selling them, or supplements dressed up as them, as a proven anti-ageing treatment: the human evidence simply isn't there yet, and the trials so far are in specific diseases, not healthy ageing. What we do believe in is the honest, physician-led version of healthy ageing — building the foundations that genuinely influence the underlying biology, applied consistently and personalised to you, and keeping a clear eye on which new science is ready for real life and which is still in the lab. The science of senescence is worth watching closely. It is not yet something to buy.
Common questions
What are senescent cells in simple terms? They're cells that have permanently stopped dividing but won't die off and be cleared away as worn-out cells normally are. Because they linger and cause trouble, they're nicknamed "zombie cells". The proper term is cellular senescence.
Are senescent cells always bad? No. In small numbers and for short periods they're genuinely useful — they help wounds heal and they help stop damaged cells from turning cancerous. The harm comes from accumulation: with age we make more of them and clear them less well, so their inflammatory signals build up.
What are senolytics? Senolytics are drugs designed to selectively kill senescent cells while sparing healthy ones. They have rejuvenated old mice in the lab. In humans, only small, early trials in specific diseases have been done — they are experimental, not an approved or proven anti-ageing treatment.
Can I take fisetin or quercetin supplements to clear zombie cells? There's no good evidence that over-the-counter supplements clear senescent cells or slow ageing in people. The doses and supervised protocols used in research are not the same as a daily capsule, so be very wary of products marketed this way.
What actually helps with senescence right now? The same foundations that influence ageing broadly: regular exercise above all, plus good nutrition, sleep, stress management and not smoking. These act on the underlying biology and are far better supported than any purchasable "senolytic".
Key takeaway
Cellular senescence is one of the clearest single ideas in ageing science: "zombie cells" that have stopped dividing but won't die, accumulating with age and poisoning their surroundings with inflammatory SASP signals — tying ageing directly to chronic inflammation and to the body's fading capacity to repair itself. Clearing these cells rejuvenates mice, which makes senolytics one of the most exciting areas of longevity research. But human evidence is still early and disease-specific, and the supplements sold on its coat-tails are not a proven shortcut. The reliable move today remains the unglamorous one: the everyday foundations, done consistently, which influence senescence and the other hallmarks all at once.
Sources
- di Micco R. et al., Nature Reviews Molecular Cell Biology (2021) — Cellular senescence in ageing: from mechanisms to therapeutic opportunities
- López-Otín C. et al., Cell (2023) — Hallmarks of aging: An expanding universe
- Baker D.J. et al., Nature (2011) — Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
- Baker D.J. et al., Nature (2016) — Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
- Xu M. et al., Nature Medicine (2018) — Senolytics improve physical function and increase lifespan in old age
- Justice J.N. et al., EBioMedicine (2019) — Senolytics in idiopathic pulmonary fibrosis: a first-in-human, open-label, pilot study
- Hickson L.J. et al., EBioMedicine (2019) — Senolytics decrease senescent cells in humans: preliminary report from a clinical trial
- Rebelo-Marques A. et al., Frontiers in Endocrinology (2018) — Aging Hallmarks: The Benefits of Physical Exercise
For general information and education only — not medical advice. Read our disclaimer.